A Phase II Trial of Abiraterone Acetate, Radiotherapy and Short-Term Androgen Deprivation in Men With Unfavorable Risk Localized Prostate Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Sep 2018
At a glance
- Drugs Abiraterone acetate (Primary) ; Goserelin; Leuprorelin; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 Sep 2017 Planned End Date changed from 1 Sep 2021 to 1 Aug 2021.
- 09 May 2017 Planned End Date changed from 1 Sep 2018 to 1 Sep 2021.